Flow-reducing implant for blood vessel with super elastic polymer foam

A super elastic polymer foam implant transitions from a constrained to an expanded configuration within a blood vessel, addressing delivery and stability issues to effectively reduce blood flow and create back pressure for treating angina.

WO2026234641A1PCT designated stage Publication Date: 2026-11-12MEDTRONIC VASCULAR INC
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
PCT/IB2026/054590
Authority / Receiving Office
WO · WO
Patent Type
Applications
Current Assignee / Owner
Priority Date
2025-05-09
Filing Date
2026-05-08
Publication Date
2026-11-12

AI Technical Summary

Technical Problem

Existing flow-reducing implants for blood vessels, such as those used to manage severe angina symptoms, face challenges in effectively delivering and maintaining a stable configuration to create back pressure and reduce blood flow without causing migration or thrombosis.

Method used

A medical device featuring a catheter with a super elastic polymer foam implant that transitions from a constrained configuration to an expanded configuration upon delivery, using a constraining force for delivery and shape memory properties to secure placement and create a longitudinal lumen for blood flow while generating back pressure.

Benefits of technology

The device efficiently delivers and secures the implant in the blood vessel, reducing blood flow and creating back pressure to treat conditions like refractory angina, with minimal migration and thrombosis risk.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure IB2026054590_12112026_PF_FP_ABST
    Figure IB2026054590_12112026_PF_FP_ABST
Patent Text Reader

Abstract

A medical device for a blood vessel includes a catheter and a flow-reducing implant. The flow-reducing implant may include a super elastic polymer foam enabling the flow-reducing implant to be configurable from a constrained configuration, in which the super elastic polymer foam is deformed from an original expanded shape into a collapsed shape by a constraining force, to an expanded configuration, in which the super elastic polymer foam recovers from its collapsed shape due to removal of the constraining force. The flow-reducing implant may define a longitudinal lumen extending therethrough to enable blood to flow therethrough while creating back pressure in the blood vessel. A method of implanting a flow-reducing implant includes delivering the flow-reducing implant at a treatment site in a blood vessel and enabling the flow-reducing implant to transition from the constrained configuration to the expanded configuration by removing the constraining force.
Need to check novelty before this filing date? Find Prior Art

Description

Attorney Docket No. A0013545W001FLOW-REDUCING IMPLANT FOR BLOOD VESSELWITH SUPER ELASTIC POLYMER FOAMFIELD

[0001] The present technology is generally related to a flow-reducing implant for a blood vessel including a super elastic polymer foam. The flow-reducing implant may be a coronary sinus reducer.BACKGROUND

[0002] A flow-reducing implant is an implantable medical device that can be used in clinically appropriate situations to aid in the management of patients with severe angina symptoms refractory to optimal medical therapy and not amenable to further revascularization. One type of flow-reducing implant comprises a flow-reducing throat providing a restriction within the coronary sinus outflow with the intention of increasing the pressure and / or diverting flow for the purpose of driving higher perfusion to the capillary bed.SUMMARY

[0003] The techniques of this disclosure generally relate to a flow-reducing implant including shape memory polymer foam.

[0004] In one aspect, the present disclosure provides a medical device for a blood vessel including a catheter and a flow-reducing implant. The catheter includes an elongate body having opposite proximal and distal end portions. The elongate body is configured to be delivered to a blood vessel so that the distal end is adjacent a treatment site of the blood vessel. The flow-reducing implant is removably coupled to the distal end portion of the elongate body. The flow-reducing implant includes a super elastic polymer foam enabling the flow-reducing implant to be configurable from a constrained configuration to an expanded configuration. In the constrained configuration, the super elastic polymer foam is deformed from an original expanded shape into a collapsed shape by a constraining force to enable delivery of the flow-reducing implant to the treatment site. In the expanded configuration, the super elastic polymer foam recovers from its collapsed shape to its original expanded shape at the treatment site due to removal of the constraining force.Attorney Docket No. A0013545W001

[0005] In another aspect, the disclosure provides a medical device for a blood vessel including a flow-reducing implant including a super elastic polymer foam enabling the flow-reducing implant to be configurable from a constrained configuration to an expanded configuration. In the constrained configuration, the super elastic polymer foam is deformed from an original expanded shape into a collapsed shape by a constraining force to enable delivery of the flow-reducing implant to the treatment site. In the expanded configuration, the super elastic polymer foam recovers from its collapsed shape to its original expanded shape at the treatment site due to removal of the constraining force. When in the expandable configuration, the flow-reducing implant defines a longitudinal lumen extending therethrough to enable blood in the blood vessel to flow therethrough while creating back pressure in the blood vessel.

[0006] In yet another aspect, the disclosure provides a method of implanting a flowreducing implant at a treatment site in a blood vessel. The method includes a step of delivering the flow-reducing implant removably coupled to the distal end portion of the elongate body. The flow-reducing implant includes a super elastic polymer foam enabling the flow-reducing implant to be configurable from a constrained configuration to an expanded configuration. In the constrained configuration, the super elastic polymer foam is deformed from an original expanded shape into a collapsed shape by a constraining force to enable delivery of the flow-reducing implant to the treatment site. In the expanded configuration, the super elastic polymer foam recovers from its collapsed shape to its original expanded shape at the treatment site due to removal of the constraining force. After delivering the flow-reducing implant to the treatment site in the blood vessel, the method includes a step of enabling the flow-reducing implant to transition from the constrained configuration to the expanded configuration by removing the constraining force.

[0007] The details of one or more aspects of the disclosure are set forth in the accompanying drawings and the description below. Other features, objects, and advantages of the techniques described in this disclosure will be apparent from the description and drawings, and from the claims.Attorney Docket No. A0013545W001BRIEF DESCRIPTION OF DRAWINGS

[0008] FIG. 1 A is a schematic illustration of a medical device including a catheter and a flow-reducing implant including a super elastic polymer foam in a constrained configuration coupled to the catheter.

[0009] FIG. IB is a schematic illustration of a distal end of the medical device of FIG.1 A disposed at a treatment site in in a blood vessel.

[0010] FIG. 2 is similar to FIG. IB including the flow-reducing implant being removed from the catheter and transitioning from the constrained configuration to an expanded configuration in the blood vessel.

[0011] FIG. 3 is a schematic illustration of the flow-reducing implant fully deployed andin the expanded configuration in the blood vessel.

[0012]

[0013] FIG. 4 is similar to FIG. 3 including anchors of the flow-reducing implant anchoring the implant to the blood vessel.

[0014] FIG. 5 is a schematic illustrating an end view of the flow-reducing implant defining a single lumen extending longitudinally through the implant and being received in the blood vessel.

[0015] FIG. 6 is a schematic illustrating an end view of another embodiment of the flow-reducing implant defining multiple lumens extending longitudinally through the implant and being received in the blood vessel.DETAILED DESCRIPTION

[0016] In general, the present description is directed to a medical device including a catheter for being delivered to a treatment site in a blood vessel, and flow-reducing implant removably coupled to the catheter. The flow-reducing implant includes a super elastic polymer foam configured to enable the flow-reducing implant to be compressed or collapsed from an expanded configuration to a constrained configuration during delivery to the treatment site and expanded at the treatment site after removing the constraint to its expanded configuration. In one embodiment, the flow-reducing implant may be used as a coronary sinus restrictor to reduce flow of blood and create back pressure in the coronary sinus.Attorney Docket No. A0013545W001

[0017] Referring to the drawings, and in particular Fig. 1 A, one embodiment of a medical device is generally indicated at reference number 10. The medical device 10 includes a catheter, generally indicated at reference number 12, and a flow-reducing implant, generally indicated at reference number 14. The flow-reducing implant 14 is suitable for being deployed in a blood vessel BV of a patient, and in particular, the coronary sinus.

[0018] Referring to Figs. 1 A and IB, the catheter 12 includes an elongate body 16 having opposite proximal and distal end portions and being sized and shaped to be inserted into and traverse along one or more blood vessels to a treatment site in a blood vessel BV. The elongate body 16 defines a cavity 22 at its distal end portion. The flow-reducing implant 14 is removably coupled to the distal end portion 20 of the elongate body 16 in the cavity 22 when in its constrained configuration. As shown in Fig. IB, the catheter 12 is used to deliver the flow-reducing implant 12 at or adjacent to a treatment site of the blood vessel BV. When the flow-reducing implant 14 is removed from the cavity 22, such as by using a deployment device explained below, the flow-reducing implant is in its expanded configuration at the treatment site of the blood vessel BV.

[0019] Referring to FIGS. 1-3, the flow-reducing implant 14 includes a biocompatible, super elastic polymer foam 24 to enable the flow-reducing implant to be configurable from its constrained configuration (Fig. 1), in which the super elastic polymer foam is deformed into a collapsed shape due to a constraining force imparted by the cavity 22 to enable delivery of the flow-reducing implant to the treatment site, to the expanded configuration (Fig. 3), in which the super elastic polymer foam recovers from its collapsed shape to its expanded recovered shape at the treatment site due to removal of the constraining force (e.g., removal of the flow-reducing implant from the catheter). .

[0020] As explained in more detail below, the super elastic polymer foam 24 may include or be formed from a shape memory polymer foam. Shape memory polymer foams exhibit super elastic properties and are also capable of shape memory upon application of an external stimulus, such as temperature. In other examples, the super elastic polymer foam 24 may include or be formed from a super elastic polymer that is not a shape memory polymer. For example, suitable super elastic polymers that are not shape memory polymer include polytetrafluoroethylene (PFTE) and ethylene-vinyl acetate (EVA).Attorney Docket No. A0013545W001

[0021] In one example, a combination of aromatic polyester polyols and polycarbonate-based polyols, as well as mixtures of these polyols with other polyols such as polyether-based polyols, and mixtures of these polyols with chain extenders (e.g., short chain aromatic or aliphatic diols or diamines) can be used to prepare the shape memory polymer foam 24. As explained above, the shape memory polymer foam 24 is super elastic, allowing for a change from the constrained configuration and the recovered configuration. In another embodiment, the shape memory polymer foam 24 may be as described in U.S. 6,583,194 or as described in Shape Memory Polymer Foams by Loredana Santo published in the Elsevier Journal in 2016. Accordingly, the U.S.6,583,194 in its entirety is in incorporated by reference herein and Shape Memory Polymer Foams in its entirety is incorporated by reference herein.

[0022] Referring to Fig. IB, in one example, the super elastic polymer foam 24 is compressed or collapsed within a cavity at the distal end of the elongate body. In this embodiment, the catheter acts as a crimping constraint on the super elastic polymer foam 24. The super elastic polymer foam 24 is crimped by contact with the elongate body 16 of the catheter 12 to selectively maintain the flow-reducing implant in its constrained configuration. When the flow-reducing implant 14 is removed from the catheter, the super elastic polymer foam 24 rebounds or recovers from its collapsed shape to its original expanded shape since the crimping constraint (i.e., constraining force) is removed, as shown in Figs. 2 and 3. This super elastic characteristic of the super elastic polymer foam 24 (e.g., shape memory polymer foam) causes the implant 14 to rapidly expand to its expanded configuration and engage the wall of the blood vessel. An alternative or additional crimping constraint may be used without departing from the present disclosure.

[0023] Referring to Fig. 3, the flow-reducing implant 14 conforms to and engages an inner surface of the blood vessel when deployed and in its expanded configuration. In an embodiment, the original expanded shape of the flow-reducing implant 14 is generally cylindrical. However, the flow-reducing implant 14 may be formed to have its original expanded configuration be an hourglass or another shape without departing from the scope of the present disclosure. The flow-reducing implant 14 may have a prismatic cross section when fully deployed within the vessel. The flow-reducing implant 14 may have other cross-sectional shapes without departing from the present disclosure. Referring to Fig. 2, the flow-reducing implant 14 may have a tapered cross section as is it deploying.Attorney Docket No. A0013545W001This may occur when the flow-reducing implant 14 remains partly crimped by the catheter 12 as the flow-reducing implant is being removed from the catheter and simultaneously expanding.

[0024] Referring to FIGS. 2 and 3, the flow-reducing implant 14 is removably coupled to the distal end portion 20 of the elongate body 16 to be delivered to treatment site of the blood vessel. In an embodiment, the medical device 10 includes a deployment mechanism, generally indicated at 30, for aiding in the deployment of the flow-reducing implant 14 from the cavity 22 of the elongate body 16 and into the blood vessel at the treatment site. After deployment, the flow-reducing implant 14 recovers due to the super elastic polymer foam expanding from its collapsed shape to its recovered expanded shape. The deployment mechanism 30 may be used to exert a pushing force against the flow-reducing implant 14 to deploy the flow-reducing implant from the catheter. For example, the deployment mechanism 30 may include a slide or actuator 32 coupled to a handle 34 of the catheter 12. The actuator 32 moves a flexible shaft 36, which may be disposed in the catheter 12, in a distal direction relative to the catheter body. Distal advancement of the shaft 36 imparts distal movement of a pusher 38 at the distal end of the shaft 36. The pusher 38 engages a proximal end of the flow-reducing implant 14 and pushes the implant distally through the open distal end of the cavity 22 and into the blood vessel, as shown in Fig. 2. The pusher 38 may form a seal with the interior surface of the catheter 12 to inhibit blood from flowing proximally through the catheter. The deployment mechanism 30 have other constructions for deploying the implant 14. Moreover, the implant 14 may be coupled to the catheter 12 in other ways suitable for deployment.

[0025] Referring to Figs. IB-3, an embodiment of a method for implanting the flowreducing implant 14 at a treatment site in a blood vessel is shown in step or operations. As shown in Fig. IB, the flow-reducing implant 14 is delivered to the treatment site in the blood vessel BV by being coupled to the catheter 12 (i.e., the flow-reducing implant is collapsed or compressed inside the cavity 22. After delivering the flow-reducing implant 14 to the treatment site in the blood vessel, the pusher 38 is advanced distally to push the flow-reducing implant 14 out of the cavity 22 and into the balloon vessel. The portions of the flow-reducing implant 14 exiting the cavity 22 expand.

[0026] The flow-reducing implant 14 is positioned within the blood vessel at the treatment site such that the longitudinal lumen 28 receives blood flow therethrough.Attorney Docket No. A0013545W001Referring to Fig. 3, the longitudinal lumen 28 enables blood to flow therethrough at the treatment site when the flow-reducing implant 14 is in the recovered configuration and at the same time restricts blood flow to create back pressure in the vessel. In one example, the blood vessel is a coronary sinus reducer suitable for creating desired back pressure for treating heart conditions, such as refractory angina, as is generally known in the art.

[0027] Referring the Fig. 3, the flow reducing implant 14 may remain within the vessel without migration due to the super elastic polymer foam creating a radially force against the vessel. For example, the super elastic polymer foam 24 of the implant 14 may produce a sufficient radial force to attach to the blood vessel without migration when the flow-reducing implant is in its recovered configuration at the treatment site. In addition, friction between an outer a surface of the implant 14 and the vessel may inhibit migration. Therefore, frictional engagement may additionally prevent migration once the flowreducing implant 14 is deployed.

[0028] Referring to Fig. 4, to further secure the flow-reducing implant 14 within the vessel, at least one anchor 26 may be used to reinforce radial force from the flow reducing implant 14 at a desired location for treatment. For example, the anchor 26 may be coupled to the flow-reducing implant 14 and coupled to the blood vessel to secure the flowreducing implant to the blood vessel when the implant is in the expanded configuration. The anchor 26 may be made through semi-ridge material, which include plastic or metal material that is biocompatible and may be biodegradable. Alternately or additionally, the flow reducing implant 14 may be secured to the vessel using an adhesive or in other ways.

[0029] Referring to Figs. 3, 5, and 6, the flow-reducing implant 14 define at least one longitudinal lumen extending therethrough. Referring to Figs. 3 and 6, the longitudinal lumen 28 may be centrally located. Referring to Fig. 7, a plurality of longitudinal lumens 28’ are spaced apart within the super elastic (e.g., shape memory) polymer foam 24. The amount and size of the longitudinal lumens 28, 28’ adjust or select a flow rate of blood through the flow-reducing implants 14, 14’.

[0030] In an embodiment, the flow-reducing implant 14 may include anti -thrombotic agent coating an interior surface defining the one or more longitudinal lumens to inhibit thrombosis and maintain patency of the one or more lumens. The remainder or a remaining portion of the flow-reducing implant 14, 14', including the super elasticAttorney Docket No. A0013545W001polymer foam 24 (such as within the cells of the foam) may be coated with an agent to promote endothelialization.

[0031] The invention may be further described by reference to the following numbered paragraphs:1. A medical device for a blood vessel comprising:a catheter including an elongate body having opposite proximal and distal end portions, wherein the elongate body is configured to be delivered to a blood vessel so that the distal end is adjacent a treatment site of the blood vessel; anda flow-reducing implant removably coupled to the distal end portion of the elongate body, wherein the flow-reducing implant comprises a super elastic polymer foam enabling the flow-reducing implant to be configurable from a constrained configuration, in which the super elastic polymer foam is deformed from an original expanded shape into a collapsed shape by a constraining force to enable delivery of the flow-reducing implant to the treatment site, to an expanded configuration, in which the super elastic polymer foam recovers from its collapsed shape to its original expanded shape at the treatment site due to removal of the constraining force.2. The medical device set forth in paragraph 1, wherein the flow-reducing implant is configured to engage an inner surface of the blood vessel at the treatment site when the flow-reducing implant is in the expanded configuration.3. The medical device set forth in any one of paragraphs 1 or 2, wherein the flow-reducing implant defines a longitudinal lumen to enable blood to flow therethrough at the treatment site when the flow-reducing implant is in the expanded configuration.4. The medical device set forth in any one of paragraphs 1-3, wherein the elongate body defines a cavity at the distal end portion, wherein the flow-reducing implant is received in the cavity in its constrained configuration, an interior surface defining the cavity imparting the constraining force to the flow-reducing implant.5. The medical device set forth in paragraph 4, further comprising a deployment mechanism configured to deploy the flow-reducing implant from the cavity and into the blood vessel at the treatment site, wherein after deployment the flow-reducing implant expands from its constrained configuration to its expanded configuration.Attorney Docket No. A0013545W0016. The medical device set forth in any one of paragraphs 4-5, wherein the flow-reducing implant is crimped within the cavity to selectively maintain the flowreducing implant in its constrained configuration.7. The medical device set forth in any one of paragraphs 6, wherein the super elastic polymer foam recovers from its collapsed shape to its recovered expanded shape when it is removed from the cavity.8. The medical device set forth in any one of paragraphs 3-7, wherein the flow-reducing implant, in its expanded configuration, conforms to an inner surface of the blood vessel when deployed.9. The medical device set forth in any one of paragraphs 1-8, wherein the flowreducing implant is generally cylindrically shaped in its expanded configuration.10. The medical device set forth in any one of paragraphs 1-9, wherein the super elastic polymer foam is configured to produce a sufficient radial force to attach to the flow-reducing implant to blood vessel without migration when the super elastic polymer foam is in its recovered expanded shape at the treatment site.11. The medical device set forth in any one of paragraphs 1-10, wherein the flow-reducing implant defines a plurality of longitudinal lumens to enable blood to flow therethrough at the treatment site when the flow-reducing implant is in the expanded configuration.12. The medical device set forth in any one of paragraphs 1-11, further comprising at least one anchor coupled to the flow-reducing implant and configured to secure the flow-reducing implant to the blood vessel in the expanded configuration.13. The medical device set forth in any one of paragraphs 1-12, wherein the super elastic polymer foam comprises shape memory polymer foam, wherein an external stimulus to which the shape memory polymer foam responds is a temperature stimulus.14. A method of implanting a flow-reducing implant at a treatment site in a blood vessel, the method comprising:delivering the flow-reducing implant removably coupled to a distal end portion of an elongate body, wherein the flow-reducing implant comprises a super elastic polymer foam enabling the flow-reducing implant to be configurable from a constrained configuration, in which the super elastic polymer foam is deformed from an original expanded shape into a collapsed shape by a constraining force to enable delivery of theAttorney Docket No. A0013545W001flow-reducing implant to the treatment site, to an expanded configuration, in which the super elastic polymer foam recovers from its collapsed shape to its original expanded shape at the treatment site due to removal of the constraining force; andenabling, after said delivering the flow-reducing implant to the treatment site in the blood vessel, the flow-reducing implant to transition from the constrained configuration to the expanded configuration by removing the constraining force.15. The method set forth in paragraph 14, further comprising pushing the flowreducing implant out of a distal end of the catheter to remove the flow-reducing implant from the catheter.16. The method set forth in any one of paragraphs 14 or 15, further comprising anchoring the flow-reducing implant to the blood vessel.17. The method set forth in any one of paragraphs 14-16, wherein after removing the flow-reducing implant from the catheter, blood flows through a longitudinal lumen defined by the flow-reducing implant and the flow-reducing implant creates back pressure in the blood vessel.18. A medical device for a blood vessel comprising:a flow-reducing implant comprising a super elastic polymer foam enabling the flow-reducing implant to be configurable from a constrained configuration, in which the super elastic polymer foam is deformed from an original expanded shape into a collapsed shape by a constraining force to enable delivery of the flow-reducing implant to a treatment site, to an expanded configuration, in which the super elastic polymer foam recovers from its collapsed shape to its original expanded shape at the treatment site due to removal of the constraining force; andwherein in the expanded configuration, the flow-reducing implant defines a longitudinal lumen extending therethrough and configured to enable blood in the blood vessel to flow therethrough while creating back pressure in the blood vessel.19. The medical device set forth in paragraph 18, wherein the super elastic polymer foam comprises shape memory polymer foam.20. The medical device set forth in paragraph 19, wherein an external stimulus to which the shape memory polymer foam responds is a temperature stimulus, and the blood vessel is a coronary sinus.Attorney Docket No. A0013545W001

[0032] It should be understood that various aspects disclosed herein may be combined in different combinations than the combinations specifically presented in the description and accompanying drawings. It should also be understood that, depending on the example, certain acts or events of any of the processes or methods described herein may be performed in a different sequence, may be added, merged, or left out altogether (e.g., all described acts or events may not be necessary to carry out the techniques). In addition, while certain aspects of this disclosure are described as being performed by a single module or unit for purposes of clarity, it should be understood that the techniques of this disclosure may be performed by a combination of units or modules associated with, for example, a medical device.

Claims

Attorney Docket No. A0013545W001WHAT IS CLAIMED IS:

1. A medical device (10) for a blood vessel (BV) comprising:a catheter (12) including an elongate body (16) having opposite proximal and distal end portions (18, 20), wherein the elongate body is configured to be delivered to a blood vessel so that the distal end is adjacent a treatment site of the blood vessel; anda flow-reducing implant (14) removably coupled to the distal end portion (20) of the elongate body, wherein the flow-reducing implant comprises a super elastic polymer foam (24) enabling the flow-reducing implant to be configurable from a constrained configuration, in which the super elastic polymer foam is deformed from an original expanded shape into a collapsed shape by a constraining force to enable delivery of the flow-reducing implant to the treatment site, to an expanded configuration, in which the super elastic polymer foam recovers from its collapsed shape to its original expanded shape at the treatment site due to removal of the constraining force.

2. The medical device (10) set forth in claim 1, wherein the flow-reducing implant (14) is configured to engage an inner surface of the blood vessel (BV) at the treatment site when the flow-reducing implant is in the expanded configuration.

3. The medical device (10) set forth in any one of claims 1 or 2, wherein the flowreducing implant (14) defines a longitudinal lumen (28) to enable blood to flow therethrough at the treatment site when the flow-reducing implant is in the expanded configuration.

4. The medical device (10) set forth in any one of claims 1-3, wherein the elongate body (16) defines a cavity (22) at the distal end portion (20), wherein the flow-reducing implant (14) is received in the cavity in its constrained configuration, an interior surface defining the cavity imparting the constraining force to the flow-reducing implant.

5. The medical device (10) set forth in claim 4, further comprising a deployment mechanism (30) configured to deploy the flow-reducing implant (14) from the cavity (22)Attorney Docket No. A0013545W001and into the blood vessel (BV) at the treatment site, wherein after deployment the flowreducing implant expands from its constrained configuration to its expanded configuration.

6. The medical device (10) set forth in any one of claims 1-5, wherein the flowreducing implant, in its expanded configuration, conforms to an inner surface of the blood vessel (BV) when deployed.

7. The medical device (10) set forth in any one of claims 1-6, wherein the super elastic polymer foam (24) is configured to produce a sufficient radial force to attach to the flow-reducing implant (14) to blood vessel (BV) without migration when the super elastic polymer foam is in its recovered expanded shape at the treatment site.

8. The medical device (10) set forth in any one of claims 1-7, further comprising at least one anchor (26) coupled to the flow-reducing implant (14) and configured to secure the flow-reducing implant to the blood vessel (BV) in the expanded configuration.

9. The medical device (10) set forth in any one of claims 1-8, wherein the super elastic polymer foam (24) comprises shape memory polymer foam, wherein an external stimulus to which the shape memory polymer foam responds is temperature stimulus.

10. A method of implanting a flow-reducing implant (14) at a treatment site in a blood vessel (BV), the method comprising:delivering the flow-reducing implant removably coupled to a distal end portion (20) of an elongate body, wherein the flow-reducing implant comprises a super elastic polymer foam (24) enabling the flow-reducing implant to be configurable from a constrained configuration, in which the super elastic polymer foam is deformed from an original expanded shape into a collapsed shape by a constraining force to enable delivery of the flow-reducing implant to the treatment site, to an expanded configuration, in which the super elastic polymer foam recovers from its collapsed shape to its original expanded shape at the treatment site due to removal of the constraining force; andAttorney Docket No. A0013545W001enabling, after said delivering the flow-reducing implant to the treatment site in the blood vessel, the flow-reducing implant to transition from the constrained configuration to the expanded configuration by removing the constraining force.

11. The method set forth in claim 10, further comprising pushing the flow-reducing implant (14) out of a distal end of the catheter (12) to remove the flow-reducing implant from the catheter.

12. The method set forth in any one of claims 10 or 11, further comprising anchoring the flow-reducing implant (14) to the blood vessel (BV).

13. A medical device (10) for a blood vessel (BV) comprising:a flow-reducing implant (14) comprising a super elastic polymer foam (24) enabling the flow-reducing implant to be configurable from a constrained configuration, in which the super elastic polymer foam is deformed from an original expanded shape into a collapsed shape by a constraining force to enable delivery of the flow-reducing implant to a treatment site, to an expanded configuration, in which the super elastic polymer foam recovers from its collapsed shape to its original expanded shape at the treatment site due to removal of the constraining force; andwherein in the expanded configuration, the flow-reducing implant defines a longitudinal lumen (28) extending therethrough and configured to enable blood in the blood vessel to flow therethrough while creating back pressure in the blood vessel.

14. The medical device (10) set forth in claim 13, wherein the super elastic polymer foam (24) comprises shape memory polymer foam.

15. The medical device (10) set forth in claim 14, wherein an external stimulus to which the shape memory polymer foam responds is a temperature stimulus, and the blood vessel (BV) is a coronary sinus.